Cargando…
Retracted: NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway
Autor principal: | and Alternative Medicine, Evidence-Based Complementary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356363/ https://www.ncbi.nlm.nih.gov/pubmed/37476339 http://dx.doi.org/10.1155/2023/9876715 |
Ejemplares similares
-
NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway
por: Zhou, Jiancheng, et al.
Publicado: (2022) -
Retracted: Quercetin Inhibits KBM7R Cell Proliferation through Wnt/β-Catenin Signaling
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Naringin Promotes Osteogenic/Odontogenic Differentiation of Dental Pulp Stem Cells via Wnt/β-Catenin
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)